Font Size: a A A
Keyword [advanced hepatocellular carcinoma]
Result: 81 - 100 | Page: 5 of 7
81. Efficacy And Safety Of Raltitrexed-based Transcatheter Arterial Chemoembolization For Intermediate And Advanced Hepatocellular Carcinoma Through Real-world Study
82. Real-world Study Of TACE-TKI-PD1 Triple Regimen And TACE-TKI Double Regimen In The Treatment Of Advanced Hepatocellular Carcinoma
83. Study Of Prognostic Model To Predict Survival After Hepatic Arterial Infusion Chemotherapy Of Oxaliplatin Plus Fluorouracil/Leucovorin For Advanced Hepatocellular Carcinoma
84. Exploration Of Response-related Factors For Hepatic Arterial Infusion Of FOLFOX Regime In Patients With Advanced Hepatocellular Carcinoma
85. Safety And Efficacy Of Radiotherapy Combined With Anti-PD-1 Immunotherapy In Advanced Hepatocellular Carcinoma
86. The Clinical Efficacy And Safety Of DEB-TACE And CTACE In The Treatment Of Advanced Hepatocellular Carcinoma:a Meta Analysis
87. Efficacy And Safety Of Anti-PD-1 Immunotherapy For Advanced Hepatocellular Carcinoma
88. The Efficacy And Safety Of Drug-eluting Bead Transarterial Chemoembolization Combined With Lenvatinib In Patients With Advanced Hepatocellular Carcinoma
89. Clinical Observation Of Immune Checkpoint Inhibitors Plus Antiangiogenic Drugs In Patients With Advanced Hepatocellular Carcinoma
90. Clinical Efficacy And Effect Of CBATO On Liver Fibrosis In Middle And Advanced Hepatocellular Carcinoma
91. Value Of Contrast-enhanced Ultrasound For Evaluating The Therapeutic Efficacy Of Immunotherapy Combined With Targeted Therapy In Patients With Advanced Hepatocellular Carcinoma
92. Analysis Of The Efficacy And Safety Of TACE Combined With Apatinib In The Treatment Of Advanced Hepatocellular Carcinoma
93. Clinical Study Of TACE Combined With Low-dose Apatinib In The Treatment Of Advanced Hepatocellular Carcinoma
94. Study On The Effect Of Apatinib In The Treatment Of Advanced Hepatocellular Carcinoma And Its Drug Resistance Mechanism
95. ZLDI-8 Enhances The In Vitro And In Vivo Therapeutic Effects Of Molecular Targeted Agent On Hepatocellular Carcinoma Cells
96. Optimization Of Drug Metabolism Capacity Of Human Primary Hepatocytes In Vitro And Feasibility Study Of Combined Immunotherapy And Targeted Downstaging For Advanced Hepatocellular Carcinoma Followed By Reoperatio
97. A Preliminary Study Of MRI-based Radiomics In Evaluating The Early-term Clinical Effects On Advanced Hepatocellular Carcinoma With Hepatic Arterial Infusion Chemotherapy(HAIC)
98. Efficacy And Influencing Factors Of Immunocheckpoint Inhibitors In The Treatment Of Advanced Hepatocellular Carcinoma
99. Analysis Between The Clinical Data Of HJURP Gene Polymorphism And The Treatment Of Apatinib Plus Tegafur-paced Chemotherapy In Advanced Hepatocellular Carcinoma
100. The Value Of Peripheral Blood M1/M2 Macrophage Ratio In Assessing The Efficacy Of PD-1 Inhibitors In The Treatment Of Advanced Hepatocellular Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to